跳至主要内容
临床试验/NCT02539706
NCT02539706已完成不适用

The Impact of the Menstrual Cycle on Injection Pain of Rocuronium

Aydin Adnan Menderes University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2014年1月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
Pain measure

研究概览

简要总结

This study evaluates the effects of rocuronium injection pain to menstrual cycle phases.Half of participants will receive follicular phase, while the other half will receive luteal phase.

详细描述

Menstrual period includes a spectrum of emotional and somatic symptoms observed in luteal phase of menstrual cycle, which are disappeared after menstruation.

During menstrual cycle, fluctuation in sexual hormones results in attitude change and alteration in pain perception.

Different studies reported some interactions between sex hormones and central nervous system, which might be linked to activity of serotonin and beta-endorphin in the brain.

Pain perception differs during menstrual cycle.

It has been recommended that estrogens might have an influence on somatic sensory process.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • American Society of Anesthesiology Classification (ASA) I-II
  • 18-45 years
  • Regular menstrual cycle

排除标准

  • Irregular menstrual cycles
  • Patients receiving hormones or drugs affecting the ovulatory cycle
  • Amenorrhea
  • Pregnancy
  • Climacteric patients

研究组 & 干预措施

Follıcular group

Experimental

patients at days 8 to 14 of the menstrual cycle were considered to be at the follicular phase and Rocuronium 0,6mg/kg intravenous rocuronium was applied.

干预措施: Rocuronium 0,6mg/kg (Drug)

Luteal group

Active Comparator

patients at days 18 to 24 of the menstrual cycle were considered to be at the luteal phase and Rocuronium 0,6mg/kg intravenous rocuronium was applied.

干预措施: Rocuronium 0,6mg/kg (Drug)

结局指标

主要结局

Pain measure

时间窗: 10 second

Tracheal intubating dose of 0.6 mg/kg of rocuronium at room temperature was injected over 10 -15 s. The patients were observed immediately if they had pain in the arm, and the response was assessed. Withdrawal movements were also assessed and scored as follows: no movements = 0, movement limited to hand = 1, movement limited to the forearm including the elbow joint = 2, and movement of the upper arm including the shoulder joint = 3

次要结局

未报告次要终点

研究者

发起方
Aydin Adnan Menderes University
申办方类型
Other
责任方
Principal Investigator
主要研究者

SİNAN YILMAZ

Associate Professor

Aydin Adnan Menderes University

研究点 (1)

Loading locations...

相似试验